Clinical Trials Directory

Trials / Completed

CompletedNCT03541746

The Value of Using Platelet Rich Plasma After Hysteroscopic Lysis of Severe Intrauterine Adhesions

The Value of Using Platelet Rich Plasma After Hysteroscopic Lysis of Severe Intrauterine Adhesions (A Randomized Controlled Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams Maternity Hospital · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers
Not accepted

Summary

The aim of present study is to evaluate the effect of the use of platelet rich plasma in decreasing recurrence of intrauterine adhesions after its lysis.

Detailed description

Research question: In women undergoing hysteroscopic adhesiolysis, does postoperative use of platelet rich plasma decrease the recurrence of intrauterine adhesions? Research hypothesis: In women undergoing hysteroscopic adhesiolysis for Asherman's syndrome, postoperative use of platelet rich plasma may decrease the recurrence of intrauterine adhesions.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet Rich PlasmaAfter hysteroscopic adhesiolysis, 30 patients will undergo once injection of 5ml PRP into the wall then lining the uterine cavity by 5ml platelet rich plasma gel. Finally, Foley balloon catheter will be inserted intrauterine then inflated and cutting its stem and to be left for two weeks.
DEVICEIntrauterine Foley's CatheterAfter hysteroscopic adhesiolysis, 30 patients will undergo intrauterine insertion of one inflated Foley balloon catheter with cutting its stem only to be left for two weeks.

Timeline

Start date
2017-04-01
Primary completion
2018-01-31
Completion
2018-01-31
First posted
2018-05-31
Last updated
2018-05-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03541746. Inclusion in this directory is not an endorsement.